Skip to content

Monro, Inc. MNRO Divestiture Deferred Proceeds Receivable

Divestiture Deferred Proceeds Receivable at other companies

Xperi logo
XperiXPER
$12M
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$312M+28.4%
Xperi logo
XperiXPER
$8.35M-55.1%
Constellium logo
ConstelliumCSTM
$2M-88.2%
Caterpillar logo
CaterpillarCAT
$0-100%
Simmons First National logo
Simmons First NationalSFNC
$0-100%

Other financials

Income statement

See full
Revenue$273.8M-7.2%
Gross profit$92.9M-4.5%
Operating income$18.6M+86.4%
Net income$11.1M+143%
EPS (diluted)$0.35+133%

Balance sheet

See full
Cash & equivalents$14.6M-29.5%
Total debt$522.7M-8.2%
Total equity$591.5M-4.7%
Total assets$1.6B-4.5%

Cash flow

See full
Operating cash flow$22.2M-23.2%
CapEx$9.8M+72.8%
Free cash flow$12.4M-46.7%

Valuation

See full
Market cap$481.91M+12.5%
Enterprise value$989.95M+1.4%
P/S0.4×+0.1×

Profitability

See full
Gross margin35%+0.1pp
Operating margin3.9%-1.4pp
Net margin-1.1%-2.7pp
FCF margin3.4%-5.5pp

Returns & leverage

See full
Return on equity-2%-5.0pp
Debt / equity0.9×0.0×
Current ratio0.5×-0.1×

Where this comes from

Reported directly by Monro, Inc. in its filing.

Tagged under the XBRL concept mnro:DivestitureDeferredProceedsReceivable.

The official record: Monro, Inc.’s 10-K, filed May 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Monro, Inc.'s divestiture deferred proceeds receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Monro, Inc.'s divestiture deferred proceeds receivable?
Monro, Inc. (MNRO) reported divestiture deferred proceeds receivable of $3.47M in Q1 2025.
What is the long-term trend for Monro, Inc.'s divestiture deferred proceeds receivable?
Over 2 years (2023 to 2025), Monro, Inc.'s divestiture deferred proceeds receivable has grown at a -58.2% compound annual growth rate (CAGR), from $19.89M to $3.47M.
What does divestiture deferred proceeds receivable mean?
This represents the portion of proceeds from the sale of a business unit or asset that is scheduled to be received in future periods. It reflects the structured nature of divestiture agreements and the company's long-term capital recovery from non-core operations. Investors use this to evaluate the total realized value of strategic portfolio shifts.